Remove 2017 Remove DEA Remove History
article thumbnail

U.S. Federal Court Tells DEA to Evaluate Rescheduling Cannabis, in Light of its Medical Benefits

WeedAdvisor

The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis.

DEA 55
article thumbnail

Charles Feldmann to Speak at Canna Tech Global

MJ Business Attorneys

Charles Feldmann, a former DEA Drug Task Force Commander and former state’s narcotics prosecutor, will be sharing his insight and expertise on the other side of the cannabis constitutional law. ” and he will be discussing the following: A brief history of the U.S. January 2017 — Inauguration Day.

DEA 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nevada Illegal Grow So Large NASA Could See It From Space

Cannabis Law Report

Last week, authorities in Nevada, along with an impressive backup of national law enforcers, raided what they called the largest illegal marijuana grow in Douglas County history, and perhaps one of the largest ever to be discovered in the state, which legalized adult-use cannabis in 2017.

DEA 52
article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Drug Enforcement Agency (“DEA”). Some physicians and therapists have argued that the Right to Try Act permits them to administer psilocybin to terminally ill patients (since studies are well past the Phase 1 stage), but the DEA has met this with resistance given psilocybin’s status as a Schedule I drug. AIMS Institute, PLLC.

Law 81
article thumbnail

Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative @ Harvard

Cannabis Law Report

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. Several trials have now been completed, with promising results, and there are many ongoing studies.

Law 81
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. Lyle Craker, Ph.D.,

article thumbnail

U.S. House Representatives Bonnie Watson Coleman & Cori Bush Unveil Federal Bill to Decriminalize Drug Possession, Replace with Health-Centered Approach

Cannabis Law Report

Prohibits the denial of employment or termination based upon a criminal history for drug possession. The Drug Policy Alliance has long advocated for drug decriminalization as a critical first step in ending the drug war, including in its 2017 report, It’s Time for the U.S. Promotes evidence-based drug education.